AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2017
Aug 2, 2017
29755_dirs_2017-08-02_779b5cd8-452e-4220-95ae-eeb895152ff5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2017-07-31
Reporting Person: Gosebruch Henry O (Chief Strategy Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-07-31 | Common stock, par value $0.01 | S | 100 | $70.37 | Disposed | 83637 | Direct |
| 2017-07-31 | Common stock, $0.01 par value | S | 200 | $70.450 | Disposed | 83437 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock, $0.01 par value | 1369 | Indirect |
Footnotes
F1: Balance in AbbVie Savings Program as of July 31, 2017.
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4